Genomic Health, Inc. (GHDX) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
301 PENOBSCOT DRIVE REDWOOD CITY, CA 94063 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8071 - Medical Laboratories (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2019 MRQ | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 214,132 | 129,575 | 96,989 | 94,943 | 103,660 | 105,350 | |||
| Cash and cash equivalents | 61,645 | 45,518 | 40,404 | 32,533 | 29,726 | 33,279 | |||
| Short-term investments | 148,149 | 84,057 | 56,585 | 62,410 | 73,934 | 72,071 | |||
| Other undisclosed cash, cash equivalents, and short-term investments | 4,338 | ||||||||
| Receivables | 51,531 | 31,161 | 35,179 | 37,164 | 34,916 | 29,446 | |||
| Other undisclosed current assets | 9,173 | 13,524 | 13,796 | 10,843 | 9,944 | 10,196 | |||
| Total current assets: | 274,836 | 174,260 | 145,964 | 142,950 | 148,520 | 144,992 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 39,532 | 46,440 | 45,688 | 39,746 | 21,860 | 18,290 | |||
| Long-term investments and receivables | 4,066 | 13,900 | 11,900 | ||||||
| Long-term investments | 4,066 | 13,900 | 11,900 | ||||||
| Other noncurrent assets | 15,938 | 10,917 | 9,462 | 1,921 | 15,541 | 13,752 | |||
| Other undisclosed noncurrent assets | (13,900) | (11,900) | |||||||
| Total noncurrent assets: | 59,536 | 57,357 | 55,150 | 41,667 | 37,401 | 32,042 | |||
| TOTAL ASSETS: | 334,372 | 231,617 | 201,114 | 184,617 | 185,921 | 177,034 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 59,176 | 39,193 | 40,944 | 39,746 | 35,333 | 26,678 | |||
| Taxes payable | 194 | 278 | |||||||
| Employee-related liabilities | 34,457 | 24,953 | 27,900 | 22,239 | 17,708 | 12,776 | |||
| Accounts payable | 8,849 | 156 | 2,864 | 8,585 | 6,987 | 5,160 | |||
| Accrued liabilities | 15,870 | 14,084 | 10,180 | 8,922 | 10,444 | 8,464 | |||
| Customer refund liability | 944 | 770 | |||||||
| Other liabilities | 600 | 323 | 231 | 208 | 208 | 292 | |||
| Deferred revenue and credits | ✕ | ✕ | 431 | 335 | 586 | ||||
| Other undisclosed current liabilities | 2,287 | 1,518 | 1,506 | ||||||
| Total current liabilities: | 59,776 | 39,516 | 41,175 | 42,672 | 38,338 | 29,832 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 4,436 | 3,810 | 3,834 | 2,410 | 2,070 | 2,221 | |||
| Other liabilities | 4,436 | 3,810 | 3,834 | 2,410 | 2,070 | 2,221 | |||
| Total noncurrent liabilities: | 4,436 | 3,810 | 3,834 | 2,410 | 2,070 | 2,221 | |||
| Total liabilities: | 64,212 | 43,326 | 45,009 | 45,082 | 40,408 | 32,053 | |||
| Equity | |||||||||
| Equity, attributable to parent | 270,160 | 188,291 | 156,105 | 139,535 | 145,513 | 144,981 | |||
| Common stock | 3 | 3 | 3 | 3 | 3 | 3 | |||
| Treasury stock, value | (30,110) | (30,110) | (30,110) | (30,110) | (30,110) | (30,110) | |||
| Additional paid in capital | 506,679 | 464,637 | 427,102 | 395,059 | 370,496 | 345,345 | |||
| Accumulated other comprehensive income (loss) | (87) | (294) | 1,198 | 2,752 | (15) | 12 | |||
| Accumulated deficit | (206,325) | (245,945) | (242,088) | (228,169) | (194,861) | (170,269) | |||
| Total equity: | 270,160 | 188,291 | 156,105 | 139,535 | 145,513 | 144,981 | |||
| TOTAL LIABILITIES AND EQUITY: | 334,372 | 231,617 | 201,114 | 184,617 | 185,921 | 177,034 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 394,111 | 340,750 | 327,868 | 287,458 | 275,706 | 261,595 | ||
| Revenue, net | ✕ | ✕ | 340,750 | 327,868 | 287,458 | 275,706 | 261,595 | |
| Cost of revenue | (49,341) | (54,718) | (57,263) | (53,782) | (48,742) | (42,100) | ||
| Cost of goods and services sold | (54,718) | (57,263) | (53,782) | (48,742) | (42,100) | |||
| Gross profit: | 344,770 | 286,032 | 270,605 | 233,676 | 226,964 | 219,495 | ||
| Operating expenses | (320,874) | (292,482) | (286,037) | (267,703) | (264,315) | (243,827) | ||
| Other undisclosed operating income | 13,724 | 12,500 | ||||||
| Operating income (loss): | 23,896 | (6,450) | (15,432) | (34,027) | (23,627) | (11,832) | ||
| Nonoperating income (expense) | 2,153 | 4,097 | (314) | (277) | (1,362) | (94) | ||
| Investment income, nonoperating | 2,385 | 3,741 | 418 | 221 | 192 | 222 | ||
| Loss, foreign currency transaction, before tax | (790) | (158) | ||||||
| Other nonoperating income (expense) | (232) | 356 | (732) | (498) | (764) | (158) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | 26,049 | (2,353) | (15,746) | (34,304) | (24,989) | (11,926) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 875 | 3,208 | 790 | (485) | ||||
| Income (loss) from continuing operations before income taxes: | 26,924 | (2,353) | (12,538) | (34,304) | (24,199) | (12,411) | ||
| Income tax expense (benefit) | (1,247) | (1,504) | (1,381) | 996 | (393) | (346) | ||
| Income (loss) from continuing operations: | 25,677 | (3,857) | (13,919) | (33,308) | (24,592) | (12,757) | ||
| Income (loss) before gain (loss) on sale of properties: | 25,677 | (3,857) | (13,919) | (33,308) | (24,592) | (12,757) | ||
| Net income (loss) available to common stockholders, diluted: | 25,677 | (3,857) | (13,919) | (33,308) | (24,592) | (12,757) | ||
Comprehensive Income ($ in thousands)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 25,677 | (3,857) | (13,919) | (33,308) | (24,592) | (12,757) | ||
| Comprehensive income (loss): | 25,677 | (3,857) | (13,919) | (33,308) | (24,592) | (12,757) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 27 | (1,492) | (1,554) | 2,767 | (27) | (3) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 25,704 | (5,349) | (15,473) | (30,541) | (24,619) | (12,760) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.